169 related articles for article (PubMed ID: 27721154)
41. Pyridazine based inhibitors of p38 MAPK.
McIntyre CJ; Ponticello GS; Liverton NJ; O'Keefe SJ; O'Neill EA; Pang M; Schwartz CD; Claremon DA
Bioorg Med Chem Lett; 2002 Feb; 12(4):689-92. PubMed ID: 11844702
[TBL] [Abstract][Full Text] [Related]
42. Medicinal chemistry optimization of antiplasmodial imidazopyridazine hits from high throughput screening of a SoftFocus kinase library: part 1.
Le Manach C; Gonzàlez Cabrera D; Douelle F; Nchinda AT; Younis Y; Taylor D; Wiesner L; White KL; Ryan E; March C; Duffy S; Avery VM; Waterson D; Witty MJ; Wittlin S; Charman SA; Street LJ; Chibale K
J Med Chem; 2014 Mar; 57(6):2789-98. PubMed ID: 24568587
[TBL] [Abstract][Full Text] [Related]
43. Synthesis, vasorelaxant activity and 2D-QSAR study of some novel pyridazine derivatives.
George RF; Saleh DO
Eur J Med Chem; 2016 Jan; 108():663-673. PubMed ID: 26735908
[TBL] [Abstract][Full Text] [Related]
44. Synthesis and biological evaluation of selective and potent cyclin-dependent kinase inhibitors.
N'gompaza-Diarra J; Bettayeb K; Gresh N; Meijer L; Oumata N
Eur J Med Chem; 2012 Oct; 56():210-6. PubMed ID: 22982525
[TBL] [Abstract][Full Text] [Related]
45. Design, synthesis, in vitro antiproliferative evaluation, and kinase inhibitory effects of a new series of imidazo[2,1-b]thiazole derivatives.
Abdel-Maksoud MS; Kim MR; El-Gamal MI; Gamal El-Din MM; Tae J; Choi HS; Lee KT; Yoo KH; Oh CH
Eur J Med Chem; 2015 May; 95():453-63. PubMed ID: 25841200
[TBL] [Abstract][Full Text] [Related]
46. Pyridazine-derived γ-secretase modulators.
Wan Z; Hall A; Jin Y; Xiang JN; Yang E; Eatherton A; Smith B; Yang G; Yu H; Wang J; Ye L; Lau LF; Yang T; Mitchell W; Cai W; Zhang X; Sang Y; Wang Y; Tong Z; Cheng Z; Hussain I; Elliott JD; Matsuoka Y
Bioorg Med Chem Lett; 2011 Jul; 21(13):4016-9. PubMed ID: 21636276
[TBL] [Abstract][Full Text] [Related]
47. Imidazo[1,5-b]pyridazine-d4T conjugates: synthesis and anti-human immunodeficiency virus evaluation.
Renoud-Grappin M; Fossey C; Fontaine G; Ladurée D; Aubertin AM; Kirn A
Antivir Chem Chemother; 1998 May; 9(3):205-23. PubMed ID: 9875400
[TBL] [Abstract][Full Text] [Related]
48. Synthesis, antileishmanial activity and structure-activity relationship of 1-N-X-phenyl-3-N'-Y-phenyl-benzamidines.
Rodrigues-Santos CE; Leon LL; Bortoluzzi AJ; Canto-Cavalheiro MM; Machado GC; Echevarria A
Eur J Med Chem; 2013 Sep; 67():166-74. PubMed ID: 23851118
[TBL] [Abstract][Full Text] [Related]
49. Synthesis and biological evaluation of imidazo[1,2-[Formula: see text]]pyridazines as inhibitors of TNF-[Formula: see text] production.
Pandit SS; Kulkarni MR; Ghosh U; Pandit YB; Lad NP
Mol Divers; 2018 Aug; 22(3):545-560. PubMed ID: 29197963
[TBL] [Abstract][Full Text] [Related]
50. Structure-activity relationship studies of imidazo[1,2-c]pyrimidine derivatives as potent and orally effective Syk family kinases inhibitors.
Hirabayashi A; Mukaiyama H; Kobayashi H; Shiohara H; Nakayama S; Ozawa M; Tsuji E; Miyazawa K; Misawa K; Ohnota H; Isaji M
Bioorg Med Chem; 2008 Oct; 16(20):9247-60. PubMed ID: 18823784
[TBL] [Abstract][Full Text] [Related]
51. Identification of triazolopyridazinones as potent p38α inhibitors.
Herberich B; Jackson C; Wurz RP; Pettus LH; Sherman L; Liu Q; Henkle B; Saris CJ; Wong LM; Chmait S; Lee MR; Mohr C; Hsieh F; Tasker AS
Bioorg Med Chem Lett; 2012 Jan; 22(2):1226-9. PubMed ID: 22196117
[TBL] [Abstract][Full Text] [Related]
52. Synthesis and evaluation of pyrazolo[1,5-b]pyridazines as selective cyclin dependent kinase inhibitors.
Stevens KL; Reno MJ; Alberti JB; Price DJ; Kane-Carson LS; Knick VB; Shewchuk LM; Hassell AM; Veal JM; Davis ST; Griffin RJ; Peel MR
Bioorg Med Chem Lett; 2008 Nov; 18(21):5758-62. PubMed ID: 18835709
[TBL] [Abstract][Full Text] [Related]
53. Using ovality to predict nonmutagenic, orally efficacious pyridazine amides as cell specific spleen tyrosine kinase inhibitors.
Lucas MC; Bhagirath N; Chiao E; Goldstein DM; Hermann JC; Hsu PY; Kirchner S; Kennedy-Smith JJ; Kuglstatter A; Lukacs C; Menke J; Niu L; Padilla F; Peng Y; Polonchuk L; Railkar A; Slade M; Soth M; Xu D; Yadava P; Yee C; Zhou M; Liao C
J Med Chem; 2014 Mar; 57(6):2683-91. PubMed ID: 24520947
[TBL] [Abstract][Full Text] [Related]
54. Enhancing the cellular anti-proliferation activity of pyridazinones as c-met inhibitors using docking analysis.
Xing W; Ai J; Jin S; Shi Z; Peng X; Wang L; Ji Y; Lu D; Liu Y; Geng M; Hu Y
Eur J Med Chem; 2015 May; 95():302-12. PubMed ID: 25827399
[TBL] [Abstract][Full Text] [Related]
55. In Silico Elucidation and Inhibition Studies of Selected Phytoligands Against Mitogen-Activated Protein Kinases of Protozoan Parasites.
Gupta CL; Akhtar S; Kumar N; Ali J; Pathak N; Bajpai P
Interdiscip Sci; 2016 Mar; 8(1):41-52. PubMed ID: 26264054
[TBL] [Abstract][Full Text] [Related]
56. Synthesis and anti-parasitic activity of a novel quinolinone-chalcone series.
Roussaki M; Hall B; Lima SC; da Silva AC; Wilkinson S; Detsi A
Bioorg Med Chem Lett; 2013 Dec; 23(23):6436-41. PubMed ID: 24119553
[TBL] [Abstract][Full Text] [Related]
57. Synthesis and biological evaluation of 2,3-dihydroimidazo[1,2-a]benzimidazole derivatives against Leishmania donovani and Trypanosoma cruzi.
Oh S; Kim S; Kong S; Yang G; Lee N; Han D; Goo J; Siqueira-Neto JL; Freitas-Junior LH; Song R
Eur J Med Chem; 2014 Sep; 84():395-403. PubMed ID: 25036797
[TBL] [Abstract][Full Text] [Related]
58. Characterization of Plasmodium falciparum cGMP-dependent protein kinase (PfPKG): antiparasitic activity of a PKG inhibitor.
Diaz CA; Allocco J; Powles MA; Yeung L; Donald RG; Anderson JW; Liberator PA
Mol Biochem Parasitol; 2006 Mar; 146(1):78-88. PubMed ID: 16325279
[TBL] [Abstract][Full Text] [Related]
59. Novel arylalkylamine compounds exhibits potent selective antiparasitic activity against Leishmania major.
Iniguez EA; Perez A; Maldonado RA; Skouta R
Bioorg Med Chem Lett; 2015 Nov; 25(22):5315-20. PubMed ID: 26410073
[TBL] [Abstract][Full Text] [Related]
60. Synthesis and in vitro evaluations of 6-(hetero)-aryl-imidazo[1,2-b]pyridazine-3-sulfonamide's as an inhibitor of TNF-α production.
Pandit SS; Kulkarni MR; Pandit YB; Lad NP; Khedkar VM
Bioorg Med Chem Lett; 2018 Jan; 28(1):24-30. PubMed ID: 29173945
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
